A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Insulin detemir
Tianeptine
The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Tianeptine.
Insulin detemir
Butriptyline
The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Butriptyline.
Insulin detemir
Amineptine
The risk or severity of adverse effects can be increased when Amineptine is combined with Levomilnacipran.
Insulin detemir
Relcovaptan
Levomilnacipran may increase the antiplatelet activities of Relcovaptan.
Insulin detemir
Buflomedil
Levomilnacipran may increase the antiplatelet activities of Buflomedil.
Insulin detemir
Linsidomine
Levomilnacipran may increase the antiplatelet activities of Linsidomine.
Insulin detemir
Cloricromen
Levomilnacipran may increase the antiplatelet activities of Cloricromen.
Insulin detemir
Picotamide
Levomilnacipran may increase the antiplatelet activities of Picotamide.
Insulin detemir
Ramatroban
Levomilnacipran may increase the antiplatelet activities of Ramatroban.
Insulin detemir
Hydroxytyrosol
Levomilnacipran may increase the antiplatelet activities of Hydroxytyrosol.
Insulin detemir
Butylphthalide
Levomilnacipran may increase the antiplatelet activities of Butylphthalide.
Insulin detemir
Ifetroban
Levomilnacipran may increase the antiplatelet activities of Ifetroban.
Insulin detemir
Naftopidil
Levomilnacipran may increase the antiplatelet activities of Naftopidil.
Insulin detemir
Trapidil
Levomilnacipran may increase the antiplatelet activities of Trapidil.
Insulin detemir
Icosapent ethyl
Levomilnacipran may increase the antiplatelet activities of Icosapent ethyl.
Insulin detemir
Tranilast
Levomilnacipran may increase the antiplatelet activities of Tranilast.
Insulin detemir
Andrographolide
Levomilnacipran may increase the antiplatelet activities of Andrographolide.
Insulin detemir
Ibudilast
Levomilnacipran may increase the antiplatelet activities of Ibudilast.
Insulin detemir
Resveratrol
Levomilnacipran may increase the antiplatelet activities of Resveratrol.
Insulin detemir
Reviparin
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Reviparin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3